Publications by authors named "Daniel Patricia"

Claim this Profile
S
Safety and preliminary immunogenicity of JNJ-64041809, a live-attenuated, double-deleted Listeria monocytogenes-based immunotherapy, in metastatic castration-resistant prostate cancer.
Charles G Drake, Russell K Pachynski, Sumit K Subudhi, Douglas G McNeel, Emmanuel S Antonarakis, Daniel Patricia

Prostate Cancer Prostatic Dis· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A drug-drug interaction study of ibrutinib with moderate/strong CYP3A inhibitors in patients with B-cell malignancies.
Jan de Jong, Peter Hellemans, Severijn De Wilde, Daniel Patricia, Tara Masterson

Leuk Lymphoma· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I trial to determine the safety, pharmacokinetics, and pharmacodynamics of intercalated BMS-690514 with paclitaxel/carboplatin (PC) in advanced or metastatic solid malignancies.
Laura Q M Chow, Derek I Jonker, Grace K Dy, Garth Nicholas, Catherine Fortin, Daniel Patricia

Cancer Chemother Pharmacol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolism, excretion, and pharmacokinetics of oral brivanib in patients with advanced or metastatic solid tumors.
Tarek Mekhail, Eric Masson, Bruce S Fischer, Jiachang Gong, Ramaswamy Iyer, Daniel Patricia

Drug Metab Dispos· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis